In addition, the discovery of potentially diagnostic biomarkers for ALS such as Neurofilament L (NfL) facilitates the biofluid-based noninvasive approaches for ALS diagnosis (8–10). This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.